QT Imaging Holdings Announces Further Expansion of Locations Offering Its Technology at Vitality Renewal, in Illinois
August 27 2024 - 8:30AM
Business Wire
QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company
engaged in research, development, and commercialization of
innovative body imaging systems, is pleased to announce further
expansion of locations offering the Breast Acoustic CT™ Scanner to
Vitality Renewal Functional Medicine, in Crystal Lake, Illinois.
The commercial shipment was made together with our strategic
business and distribution partner.
Dr. Yvonne Karney, founder of Vitality Renewal Functional
Medicine, has been an obstetrics and gynecology doctor for 25
years. Dr. Karney served in the Air Force for 8 years.
“I cannot be more excited that QTI’s Breast Acoustic CT Scanner™
will be available in Chicagoland this summer! The QTscan™ is the
first non-invasive breast imaging technology that provides a true
3D image of the breast’s microanatomy down to a few hundred cells
without compression or harmful radiation. FDA cleared, and more
accurate than mammography and hand-held ultrasound at identifying
certain breast structures, the QTscan™ algorithm can systematically
strip away normal tissues to expose an underlying mass deep within
the dense breast tissue,” said Dr. Karney. “The goal of mammography
is to detect cancer early, making treatment easier and resulting in
a lower death rate from breast cancer, but there are a few
substantial limitations of this imaging modality, which has been
the standard of care for decades. Not all breast cancers have
calcifications, and these are missed with mammography1. For women
with dense breasts, meaning a higher ratio of fibrous to fat
tissue, the mammogram is difficult to interpret. This is a
significant limitation, because over 40% of women have dense
breasts.2 Half of women screened over a 10-year period will have a
false positive mammogram. This occurs when the call-back for
additional views and possible procedures ends up being
non-cancerous. While around 12% of 2-D screening mammograms are
recalled for more work-up, only 4.4% of those recalls, or 0.5%
overall, conclude with a cancer diagnosis.3 Women deserve to know
ALL the facts and be championed for making their own
decisions.”
“The QTI team is very proud every time we ship a scanner to
another location in the U.S. and doctors such as Dr. Karney get to
offer our breast imaging technology to women. Our commitment is to
keep doing this until all women will have a choice,” said Dr.
Raluca Dinu, Chief Executive Officer at QTI.
About QT Imaging Holding, Inc.
QT Imaging Holdings, Inc. is a public (NASDAQ: QTI) medical
device company engaged in research, development, and
commercialization of innovative body imaging systems using low
frequency sound waves. QT Imaging Holdings, Inc. strives to improve
global health outcomes. Its strategy is predicated upon the fact
that medical imaging is critical to the detection, diagnosis, and
treatment of disease and that it should be safe, affordable,
accessible, and centered on the patient’s experience. For more
information on QT Imaging Holdings, Inc., please visit the
company’s website at www.qtimaging.com.
Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging
Holdings, Inc.
About Vitality Renewal Functional Medicine
Learn more at Home | Vitality Renewal | Dr. Yvonne Karney.
References
(1)
https://www.mdanderson.org/cancerwise/What-is-invasive-lobular-carcinoma-8-insights-on-lobular-breast-cancer.h00-159539745.html
(2)
https://www.cancer.gov/types/breast/breast-changes/dense-breasts
(3)
Ho TH, Bissell MCS, Kerlikowske K, et al.
Cumulative Probability of False-Positive Results After 10 Years of
Screening With Digital Breast Tomosynthesis vs Digital Mammography.
JAMA Netw Open. 2022;5(3):e222440.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Such statements contain words such as “will,” and
“expect,” or the negative thereof or comparable terminology, and
include (without limitation) statements regarding the shipment by
QT Imaging Holdings to the Vitality Renewal Functional Medicine of
a Breast Acoustic CT™ Scanner, plans for QT Imaging Holdings, new
product development and introduction, and product sales growth and
projected revenues. Forward-looking statements involve certain
risks and uncertainties, and actual results may differ materially
from those discussed in any such statement. These risks include,
but are not limited to: research results from the use of the Breast
Acoustic CT™ Scanner, the ability of QT Imaging Holdings to sell
and deploy the Breast Acoustic CT™ Scanner, the ability to extend
product offerings into new areas or products, the ability to
commercialize technology, unexpected occurrences that deter the
full documentation and “bring to market” plan for products, trends
and fluctuations in the industry, changes in demand and purchasing
volume of customers, unpredictability of suppliers, the ability to
attract and retain qualified personnel and the ability to move
product sales to production levels. Additional factors that could
cause actual results to differ are discussed under the heading
“Risk Factors” and in other sections of QT Imaging Holding’s (and
its predecessor, GigCapital5, Inc.) filings with the SEC, and in
its other current and periodic reports filed or furnished from time
to time with the SEC. All forward-looking statements in this press
release are made as of the date hereof, based on information
available to QT Imaging Holdings as of the date hereof, and QT
Imaging Holdings assumes no obligation to update any
forward-looking statement.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240827790498/en/
For media inquiries, please contact: Susan Schaffler Head
of Communications Susan.Schaffler@qtimaging.com
Stas Budagov Chief Financial Officer
Stas.Budagov@qtimaging.com
QT Imaging (NASDAQ:QTI)
Historical Stock Chart
From Sep 2024 to Oct 2024
QT Imaging (NASDAQ:QTI)
Historical Stock Chart
From Oct 2023 to Oct 2024